METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF PATIENTS WITH NON-HODGKIN LYMPHOMAS WITH BONE MARROW INVOLVEMENT Russian patent published in 2014 - IPC G01N33/483 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncohaematology, and can be used for prediction of the clinical effectiveness in the patients with non-Hodgkin lymphomas with bone marrow involvement. That is ensured by determining a lymphocyte volume and electric conductivity in patient's peripheral blood before the treatment and every next course of the chemotherapy with calculating a relation of the values. If observing a decrease of the relations as compared to the initial value, the positive clinical effectiveness and the absence of generalisation symptoms are predicted. The absence of the decrease or increase of the relations shows the absence or low clinical effectiveness and the presence of the symptoms of a continued tumour growth.

EFFECT: using of given method enables determining the sensitivity of the patients suffering non-Hodgkin lymphomas to the chemotherapy and performing the immediate and remote prediction of the clinical course of the disease.

1 tbl, 3 ex